Justin M Balko Selected Research

Justin M Balko Research Topics

Disease

95	Neoplasms (Cancer) 04/2024 - 11/2006
58	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2009
21	Triple Negative Breast Neoplasms 04/2024 - 03/2013
18	Melanoma (Melanoma, Malignant) 11/2023 - 01/2016
6	Bites and Stings (Sting) 12/2023 - 01/2019
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 11/2006
5	Disease Progression 01/2021 - 01/2017
5	Lung Neoplasms (Lung Cancer) 05/2020 - 11/2006
4	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2009
4	Myocarditis (Carditis) 11/2022 - 11/2016
4	Pathologic Complete Response 01/2022 - 07/2013
3	COVID-19 01/2021 - 05/2020
3	Residual Neoplasm 01/2019 - 07/2012
3	Inflammation (Inflammations) 01/2019 - 01/2018
2	Genetic Risk Score 03/2024 - 09/2023
2	Colitis 03/2024 - 09/2023
2	Ulcerative Colitis 03/2024 - 09/2023
2	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 01/2019
1	Inflammatory Breast Neoplasms 01/2024
1	Overweight 11/2023
1	Neutropenia 11/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2023
1	Turcot syndrome 01/2023
1	Obesity 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Atherosclerosis 01/2022
1	Heart Failure 01/2022

Drug/Important Bio-Agent (IBA)

34	Immune Checkpoint InhibitorsIBA 04/2024 - 03/2016
20	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2006
17	LigandsIBA 04/2024 - 11/2006
15	Estrogen ReceptorsIBA 01/2023 - 04/2011
14	Hormones (Hormone)IBA 11/2023 - 04/2011
11	RNA (Ribonucleic Acid)IBA 01/2024 - 03/2013
11	InterferonsIBA 12/2023 - 01/2018
10	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2017 - 04/2011
9	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2006
9	Estrogens (Estrogen)FDA Link 02/2019 - 04/2011
9	Letrozole (Femara)FDA LinkGeneric 01/2019 - 04/2011
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020 - 03/2009
7	CytokinesIBA 01/2021 - 11/2014
6	AntigensIBA 01/2023 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2014
6	Phenobarbital (Luminal)FDA Link 01/2023 - 08/2013
6	Aromatase InhibitorsIBA 08/2017 - 04/2011
5	B7-H1 AntigenIBA 11/2023 - 04/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2009
4	ChemokinesIBA 01/2022 - 01/2018
4	AlpelisibIBA 01/2019 - 07/2013
4	Fulvestrant (Faslodex)FDA Link 01/2019 - 11/2011
4	Tyrosine Kinase InhibitorsIBA 10/2017 - 11/2006
4	ErbB Receptors (EGF Receptor)IBA 08/2017 - 11/2006
4	Phosphotransferases (Kinase)IBA 01/2016 - 11/2006
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2023 - 11/2016
3	HLA-DR Antigens (HLA-DR)IBA 10/2021 - 01/2016
3	AntibodiesIBA 10/2021 - 01/2016
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2021 - 01/2019
3	ParaffinIBA 01/2021 - 12/2014
3	human ERBB2 proteinIBA 01/2021 - 08/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2019 - 03/2009
3	Trastuzumab (Herceptin)FDA Link 01/2019 - 03/2011
3	Lapatinib (GW572016)FDA Link 01/2019 - 07/2013
3	NVP-BKM120IBA 01/2019 - 04/2014
2	palbociclibIBA 11/2023 - 01/2019
2	ChromatinIBA 11/2023 - 09/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2020
2	protein phosphatase 4IBA 01/2022 - 07/2012
2	pembrolizumabIBA 10/2021 - 01/2019
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 09/2020
2	Nucleic AcidsIBA 01/2021 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2021 - 10/2017
2	130-nm albumin-bound paclitaxelIBA 11/2020 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2018
2	c-Mer Tyrosine KinaseIBA 01/2019 - 11/2014
2	NivolumabIBA 01/2019 - 11/2016
2	pertuzumabIBA 01/2019 - 08/2013
2	Blocking AntibodiesIBA 01/2019 - 11/2016
2	guadecitabineIBA 03/2018 - 01/2018
2	MethyltransferasesIBA 03/2018 - 01/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 01/2009
2	Messenger RNA (mRNA)IBA 01/2015 - 07/2013
2	ClaudinsIBA 10/2013 - 08/2013
2	Monoclonal AntibodiesIBA 11/2011 - 05/2009
2	Tamoxifen FDA LinkGeneric 11/2011 - 04/2011
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	Docetaxel (Taxotere)FDA Link 04/2024
1	ruxolitinibIBA 01/2024
1	TransposasesIBA 11/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Myosins (Myosin)IBA 11/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021

Therapy/Procedure

55	Therapeutics 04/2024 - 01/2009
29	Immunotherapy 04/2024 - 03/2016
16	Drug Therapy (Chemotherapy) 04/2024 - 07/2012
13	Neoadjuvant Therapy 01/2022 - 04/2011
3	Aftercare (After-Treatment) 11/2016 - 12/2014
2	Intravenous Administration 12/2023 - 10/2021